Insider: BENZENO SHARON Chief Commercial Ofc Imm Med - Adaptive Biotechnologies Corp
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 272,751 | 0 | 272,751 |
| Value | $4,039,442.31 | $0.00 | $4,039,442.31 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/11/2026 | DDS | 63,103 | Direct | COM | $13.17 | $831,066.51 | 272,751 |
| 12/04/2025 | DDS | 12,604 | Direct | COM | $16.85 | $212,377.40 | 296,791 |
| 11/21/2025 | DDS | 308,477 | Direct | COM | $16.91 | $5,216,346.07 | 296,791 |
| 11/20/2025 | DDS | 297,925 | Direct | COM | $16.54 | $4,927,679.50 | 296,791 |
| 03/05/2025 | DDS | 41,600 | Direct | COM | $6.98 | $290,368.00 | 395,788 |
| 03/05/2025 | DDS | 3,065 | Direct | COM | $6.99 | $21,424.35 | 392,723 |
| 03/05/2024 | DDS | 10,746 | Direct | COM | $3.43 | $36,858.78 | 346,059 |
| 03/05/2024 | DDS | 18,644 | Direct | COM | $3.44 | $64,135.36 | 327,415 |
| 03/06/2023 | DDS | 11,749 | Direct | COM | $8.57 | $100,688.93 | 223,826 |
| 03/07/2022 | DDS | 2,670 | Direct | COM | $12.01 | $32,066.70 | 102,596 |
| 03/15/2021 | DDS | 340 | Direct | COM | $41.22 | $14,014.80 | 23,908 |
| 03/15/2021 | DDS | 1,014 | Direct | COM | $41.85 | $42,435.90 | 22,894 |
| 03/01/2021 | DDS | 561 | Direct | COM | $58.17 | $32,633.37 | 0 |
| 03/01/2021 | DDS | 6,210 | Direct | COM | $57.57 | $357,509.70 | 561 |
| 02/19/2021 | DDS | 416 | Direct | COM | $61.20 | $25,459.20 | 0 |
| 02/16/2021 | DDS | 5,022 | Direct | COM | $63.42 | $318,495.24 | 11,228 |
| 02/16/2021 | DDS | 1,700 | Direct | COM | $64.59 | $109,803.00 | 9,528 |
| 02/16/2021 | DDS | 9,528 | Direct | COM | $65.29 | $622,083.12 | 0 |
| 02/01/2021 | DDS | 6,470 | Direct | COM | $55.61 | $359,796.70 | 300 |
| 02/01/2021 | DDS | 300 | Direct | COM | $56.41 | $16,923.00 | 0 |
| 01/19/2021 | DDS | 417 | Direct | COM | $69.00 | $28,773.00 | 0 |
| 01/04/2021 | DDS | 2,209 | Direct | COM | $56.12 | $123,969.08 | 4,562 |
| 01/04/2021 | DDS | 3,800 | Direct | COM | $57.82 | $219,716.00 | 762 |
| 01/04/2021 | DDS | 495 | Direct | COM | $58.63 | $29,021.85 | 267 |
| 01/04/2021 | DDS | 267 | Direct | COM | $59.46 | $15,875.82 | 0 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research